These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1747441)

  • 1. Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.
    Lumley CE
    Adverse Drug React Toxicol Rev; 1991; 10(3):143-53. PubMed ID: 1747441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations.
    Paumgartten F; Solecki R; Buschmann J; Clark R; Grote K; Rauch M; Chahoud I
    Reprod Toxicol; 2009 Jan; 27(1):8-13. PubMed ID: 19121384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive toxicity testing for pharmaceuticals under ICH.
    Barrow PC
    Reprod Toxicol; 2009 Sep; 28(2):172-9. PubMed ID: 19631153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current developments in reproductive toxicity testing of pesticides.
    Cooper RL
    Reprod Toxicol; 2009 Sep; 28(2):180-7. PubMed ID: 19409482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in assessing the developmental and reproductive toxicity potential of biopharmaceuticals.
    Martin PL; Breslin W; Rocca M; Wright D; Cavagnaro J
    Birth Defects Res B Dev Reprod Toxicol; 2009 Jun; 86(3):176-203. PubMed ID: 19462404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
    Dent MP
    Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryo-fetal developmental toxicity study design for pharmaceuticals.
    Wise LD; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Lerman SA; Ooshima Y; Stump DG
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):418-28. PubMed ID: 20025038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal toxicology studies on new medicines and their relationship to clinical exposure: a review of international recommendations.
    Scales MD; Mahoney K
    Adverse Drug React Toxicol Rev; 1991; 10(3):155-68. PubMed ID: 1747442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure.
    Bernauer U; Heinemeyer G; Heinrich-Hirsch B; Ulbrich B; Gundert-Remy U
    Toxicol Lett; 2008 Jan; 176(1):68-76. PubMed ID: 18068317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and reproductive toxicology studies in nonhuman primates.
    Chellman GJ; Bussiere JL; Makori N; Martin PL; Ooshima Y; Weinbauer GF
    Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):446-62. PubMed ID: 20025046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview: developmental toxicology: new directions.
    Shuey D; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):381-3. PubMed ID: 21770024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of developmental and reproductive toxicity risk assessment in China.
    Wang H; Wang Q; Liao M
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):2-8. PubMed ID: 20077514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.